Investing.com -- Oppenheimer downgraded Freshpet Inc (NASDAQ:FRPT) to "Perform" from "Outperform," citing a weaker-than-expected start to the year and more cautious management commentary. The firm believes investors should wait for clearer signs of revenue stabilization before considering a potential turnaround.
“We now find it harder to call a bottom in shares and view the risk/reward as balanced,” analyst said as it removed the previous $140 price target.
Oppenheimer has also trimmed its sales estimates for Freshpet, now expecting full-year growth to align with first-quarter trends.
The firm noted that Freshpet shares have historically bottomed at around three times price-to-sales, which could suggest further downside into the $70 range. Given recent momentum at Chewy (NYSE:CHWY), Oppenheimer now views the pet retailer more favorably than Freshpet in the near term.
Despite the downgrade, Oppenheimer still considers Freshpet a potential acquisition target over the longer term.
However, in the current market environment, where investors are shifting away from high-risk names, the firm sees limited upside in the stock.
Freshpet was also removed from Oppenheimer’s top consumer staples picks, which now include more defensive names such as Church&Dwight (NYSE:CHD), Prestige Consumer Healthcare, and Walmart (NYSE:WMT), as well as discretionary stocks like Target and Ulta Beauty (NASDAQ:ULTA).
Although Freshpet has long-term growth drivers, including product innovation, household penetration, and global expansion, Oppenheimer sees near-term challenges.
With disappointing guidance at the recent Consumer Analyst Group of New York (CAGNY) conference and a more cautious tone from management, the firm believes it is prudent to take a wait-and-see approach before expecting a reacceleration in sales.
Related Articles
Oppenheimer downgrades Freshpet on turnaround uncertainty after slow start to year
Puma sees quarterly sales drop on US, China performance
US agency recommends restrictions on helicopters after Washington mid-air collision
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。